USPTO serial 79340032
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rhett V. Barney
Rhett V. Barney Lee & Hayes, PC601 W. Riverside Ave. Suite 1400Spokane, WA 99201UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | chemical preparations for pharmaceutical purposes, namely, for calibration of diagnostics tests in a form of a glycoprotein standard; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for diagnosis of oncological diseases, autoimmune diseases and neurological diseases; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases | ACTIVE | — |
| 010 | Blood testing apparatus; testing apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids; diagnostic apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids | ACTIVE | — |
| 035 | Retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases; online retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases | ACTIVE | — |
| 040 | Custom manufacture of medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases | ACTIVE | — |
| 041 | Educational services in the nature of academies, namely, conducting seminars, workshops, lectures, practical experimental demonstrations in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of colloquiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of conferences in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of congresses in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of seminars in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of symposiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of in-person educational forums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics | ACTIVE | — |
| 042 | Chemical analysis; chemical research; biological research; scientific laboratory services; scientific research; medical and scientific research, namely, conducting clinical validations trials for diagnostic and pharmaceutical companies; medical research | ACTIVE | — |
| 044 | Medical services; pharmacy advice, namely, pharmaceutical advice for diagnostic and pharmaceutical companies; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratories | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 8, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 14, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 14, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 12, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 12, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 12, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 27, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 27, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 7, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 12, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 12, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 12, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 13, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 13, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 13, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 4, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 9, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 17, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 13, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 12, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |